185 related articles for article (PubMed ID: 31857793)
1. hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing.
Peng WZ; Liu JX; Li CF; Ma R; Jie JZ
Cancer Cell Int; 2019; 19():335. PubMed ID: 31857793
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
[TBL] [Abstract][Full Text] [Related]
3. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
Bennett KL; Modrell B; Greenfield B; Bartolazzi A; Stamenkovic I; Peach R; Jackson DG; Spring F; Aruffo A
J Cell Biol; 1995 Dec; 131(6 Pt 1):1623-33. PubMed ID: 8522617
[TBL] [Abstract][Full Text] [Related]
4. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
[TBL] [Abstract][Full Text] [Related]
5. MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.
Liu L; Luo C; Luo Y; Chen L; Liu Y; Wang Y; Han J; Zhang Y; Wei N; Xie Z; Wu W; Wu G; Feng Y
Oncogene; 2018 Jan; 37(1):86-94. PubMed ID: 28869607
[TBL] [Abstract][Full Text] [Related]
6. Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma.
Lo CW; Chan CKW; Yu J; He M; Choi CHJ; Lau JYW; Wong N
Nanotheranostics; 2022; 6(2):161-174. PubMed ID: 34976591
[No Abstract] [Full Text] [Related]
7. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
8. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.
Hiraga T; Nakamura H
Oncol Lett; 2016 Oct; 12(4):2962-2969. PubMed ID: 27698884
[TBL] [Abstract][Full Text] [Related]
9. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract][Full Text] [Related]
10. HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway.
Huang H; Han Y; Yang X; Li M; Zhu R; Hu J; Zhang X; Wei R; Li K; Gao R
Oncotarget; 2017 Nov; 8(61):103364-103374. PubMed ID: 29262567
[TBL] [Abstract][Full Text] [Related]
11. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
[TBL] [Abstract][Full Text] [Related]
12. hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression.
Peng WZ; Zhao J; Liu X; Li CF; Si S; Ma R
Cancer Cell Int; 2021 May; 21(1):281. PubMed ID: 34044823
[TBL] [Abstract][Full Text] [Related]
13. The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR.
Zhou D; Zhu X; Wu X; Zheng J; Tou L; Zhou Y
Exp Ther Med; 2021 Aug; 22(2):798. PubMed ID: 34093754
[TBL] [Abstract][Full Text] [Related]
14. CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
[TBL] [Abstract][Full Text] [Related]
15. Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.
Tripathi V; Sixt KM; Gao S; Xu X; Huang J; Weigert R; Zhou M; Zhang YE
Mol Cell; 2016 Nov; 64(3):549-564. PubMed ID: 27746021
[TBL] [Abstract][Full Text] [Related]
16. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
Zhang P; Feng S; Liu G; Wang H; Fu A; Zhu H; Ren Q; Wang B; Xu X; Bai H; Dong C
Oncogene; 2016 Sep; 35(38):5056-5069. PubMed ID: 27041584
[TBL] [Abstract][Full Text] [Related]
17. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
[TBL] [Abstract][Full Text] [Related]
18. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
Loh TJ; Cho S; Moon H; Jang HN; Williams DR; Jung DW; Kim IC; Ghigna C; Biamonti G; Zheng X; Shen H
Biochim Biophys Acta; 2015 Jun; 1849(6):743-50. PubMed ID: 25623890
[TBL] [Abstract][Full Text] [Related]
19. CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization.
Xia Y; Lv J; Jiang T; Li B; Li Y; He Z; Xuan Z; Sun G; Wang S; Li Z; Wang W; Wang L; Xu Z
J Exp Clin Cancer Res; 2021 Mar; 40(1):103. PubMed ID: 33731207
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
